Lartruvo Interactions
There are 156 drugs known to interact with Lartruvo (olaratumab), along with 2 disease interactions. Of the total drug interactions, 46 are major, and110 are moderate.
- View all 156 medications that may interact with Lartruvo
- View Lartruvo disease interactions (2)
Most frequently checked interactions
View interaction reports for Lartruvo (olaratumab) and the medicines listed below.
- Abilify MyCite (aripiprazole)
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Afinitor Disperz (everolimus)
- Afstyla (antihemophilic factor)
- Aggrenox (aspirin / dipyridamole)
- Akynzeo (netupitant / palonosetron)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- Alprazolam Intensol (alprazolam)
- Amicar (aminocaproic acid)
- amoxicillin
- Apresazide (hydralazine / hydrochlorothiazide)
- Aptivus (tipranavir)
- Arava (leflunomide)
- Aricept (donepezil)
- Arzerra (ofatumumab)
- Asendin (amoxapine)
- Atarax (hydroxyzine)
- ATNAA (atropine / pralidoxime)
- Atripla (efavirenz / emtricitabine / tenofovir disoproxil)
- Atrovent (ipratropium)
- Aubagio (teriflunomide)
- Austedo (deutetrabenazine)
- Avandia (rosiglitazone)
- Avastin (bevacizumab)
Lartruvo disease interactions
There are 2 disease interactions with Lartruvo (olaratumab) which include:
More about Lartruvo (olaratumab)
- Lartruvo consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.